In conclusion, our study identifies the NLRP3/PERK/eIF2 axis as a novel driving force in AML and provides evidence that targeting NLRP3 induces apoptosis and autophagy through PERK-mediated eIF2α phosphorylation without impacting AML cell proliferation. Here, EIF2AK3 is linked to acute myeloid leukemia.